Bénéfices et risques de la stimulation ovarienneen vue d’inséminations intra-utérines
review
OA: closed
CC0
AI-generated summary
This paper examined the benefits and risks associated with ovarian stimulation for intrauterine insemination procedures.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Performance of intra-uterine insemination (IIU) is generally advocated as a first line therapy for infertility related to cercical hostility, male factor, unexplained infertility or mild endometriosis. IIU are usually performed following stimulation of ovulation, even in absence of anovulation. However the rationale for such a systematic ovulation induction is still questionable. Indeed, while an overall assessment of ovarian stimulation tends to conclude to a beneficial effect of these treatments in unexplained or some male infertility, it is clear that no definitive conclusion can be drawn. Indeed, the methodology in many published series is mostly inadequate, data are usually not analysed according to the type of infertility or to the female hormonal features. Finally, adverse effects are imperfectly descripted. A more accurate analysis of these data in relation to the number of recruited follicles definitively shows that, if a bifollicular development is associated with a significant increase in the pregnancy rates, there is no advantage to stimulate further the ovary. Indeed, surpassing the recruitment of two follicles would lead to dramatically increase the risk of OHSS and multiple pregnancies. Thus, further investigations including prospective, randomized studies are needed to better define what should be the most adequate regimen of ovulation induction. Specifically, tailoring the rate of multifollicular development according to the duration, the type of infertility (etiology; primary or secondary; female age) would prove to be a safer approach for getting pregnancy as well as avoiding adverse effects. Such a policy remains to be determined in the light of further clinical studies conducted in the more appropriate manner.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (39)
- A randomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility. via openalex
- Efficacy of treatment for unexplained infertility via openalex
- Factors responsible for multiple pregnancies after ovarian stimulation and intrauterine insemination with gonadotropins via openalex
- Higher Pregnancy Rates Following Treatment of Cervical Factor with Intrauterine Insemination Without Superovulation Versus Intercourse: The Importance of a Well-Timed Postcoital Test for Infertility via openalex
- Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis via openalex
- Relationship of follicle number, serum estradiol, and other factors to birth rate and multiparity in human menopausal gonadotropin-induced intrauterine insemination cycles via openalex
- The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a meta-analysis via openalex
- W2042867431 via openalex
- W2054120734 via openalex
- W2073318434 via openalex
- W2081325974 via openalex
- W2089731163 via openalex
- W2096597100 via openalex
- W2108341258 via openalex
- W2148492753 via openalex
- W2152527116 via openalex
- W2162541194 via openalex
- W2170072223 via openalex
- W2271756956 via openalex
- W2283625088 via openalex
- W2333023845 via openalex
- W2396509416 via openalex
- W2401013134 via openalex
- W2401135632 via openalex
- W2407215749 via openalex
- W2409703744 via openalex
- W2410930576 via openalex
- W2418009020 via openalex
- W2438855736 via openalex
- W2506645050 via openalex
- W4249806119 via openalex
- W6717415692 via openalex
- W6718435148 via openalex
- W195597829 via openalex
- W1489890885 via openalex
- W1877509398 via openalex
- W1943370336 via openalex
- W1973502585 via openalex
- W2019780477 via openalex
Source provenance
- europepmc
- last seen: 2026-07-28T06:14:09.330459+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:30.513821+00:00
- unpaywall
- last seen: 2026-07-28T06:55:22.213180+00:00
License: CC0
· commercial use OK